Teva Pharmaceutical Industries (TEVA) Gross Profit Growth (1y) (2017 - 2026)

Teva Pharmaceutical Industries (TEVA) Gross Profit Growth (1y) (2017 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Profit Growth (1y) (Qtr)
1 Teva Pharmaceutical Industries 36.44 Bn 32.71 Bn 1.97 Bn 5.06%
2 Zoetis 33.18 Bn 31.24 Bn 1.62 Bn 2.59%
3 United Therapeutics 23.36 Bn 21.20 Bn 648.10 Mn -7.66%
4 Neurocrine Biosciences 15.90 Bn 14.58 Bn 800.70 Mn 42.12%
5 Aurora Cannabis 15.07 Bn 14.99 Bn 21.72 Mn 49.07%
6 Elanco Animal Health 12.06 Bn 11.63 Bn 785.00 Mn 14.77%
7 Hims & Hers Health 8.09 Bn 7.34 Bn 396.79 Mn -7.87%
8 Alkermes 7.47 Bn 6.96 Bn -116.06 Mn -163.22%
9 Lantheus Holdings 6.69 Bn 6.19 Bn 230.92 Mn -2.85%
10 Liquidia 6.26 Bn 6.03 Bn 121.79 Mn 7,497.38%

Historic Data

Download Data
DateValue
Mar 31, 2026 5.06%
Dec 31, 2025 25.22%
Sep 30, 2025 7.26%
Jun 30, 2025 3.85%
Mar 31, 2025 5.99%
Dec 31, 2024 -12.21%
Sep 30, 2024 16.05%
Jun 30, 2024 12.69%
Mar 31, 2024 11.95%
Dec 31, 2023 36.50%
Sep 30, 2023 10.90%
Jun 30, 2023 0.11%
Mar 31, 2023 -9.08%
Dec 31, 2022 -13.66%
Sep 30, 2022 -6.97%
Jun 30, 2022 -4.22%
Mar 31, 2022 -7.35%
Dec 31, 2021 0.10%
Sep 30, 2021 -3.13%
Jun 30, 2021 6.24%